麻醉疼痛科指南

订阅

MedSci主页 / 所有栏目 / 麻醉疼痛科指南

2021 SPAQI共识声明：胃肠道和肺部用药的术前处理

2021-11-01 围术期评估和质量改进学会 Mayo Clin Proc

门诊和手术室外麻醉胃肠药和肺部用药的术前处理

2021年11月，围术期评估和质量改进学会(SPAQI)发布了胃肠药和肺部用药的术前处理共识声明。围手术期药物管理是术前优化的组成部分，但由于缺乏文献指导仍具有挑战性。

中文标题：

2021 SPAQI共识声明：胃肠道和肺部用药的术前处理

英文标题：

Preoperative Management of Gastrointestinal and Pulmonary Medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement

发布机构：

围术期评估和质量改进学会

发布日期：

2021-11-01

简要介绍：

2021年11月，围术期评估和质量改进学会(SPAQI)发布了胃肠药和肺部用药的术前处理共识声明。围手术期药物管理是术前优化的组成部分，但由于缺乏文献指导仍具有挑战性。本文主要针对胃肠道和肺部用药的术前处理提供共识指导。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 SPAQI共识声明：胃肠道和肺部用药的术前处理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e5cea1c00225e53c, title=2021 SPAQI共识声明：胃肠道和肺部用药的术前处理, enTitle=Preoperative Management of Gastrointestinal and Pulmonary Medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement, guiderFrom=Mayo Clin Proc, authorId=0, author=, summary=2021年11月，围术期评估和质量改进学会(SPAQI)发布了胃肠药和肺部用药的术前处理共识声明。围手术期药物管理是术前优化的组成部分，但由于缺乏文献指导仍具有挑战性。, cover=https://img.medsci.cn/2021118/1636378980309_1608702.jpg, journalId=0, articlesId=null, associationId=2111, associationName=围术期评估和质量改进学会, associationIntro=围术期评估和质量改进学会(SPAQI,Society for Perioperative Assessment and Quality Improvement), copyright=0, guiderPublishedTime=Mon Nov 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年11月，围术期评估和质量改进学会(SPAQI)发布了胃肠药和肺部用药的术前处理共识声明。围手术期药物管理是术前优化的组成部分，但由于缺乏文献指导仍具有挑战性。本文主要针对胃肠道和肺部用药的术前处理提供共识指导。</span></p>, tagList=[TagDto(tagId=117285, tagName=门诊和手术室外麻醉), TagDto(tagId=117286, tagName=胃肠药和肺部用药的术前处理)], categoryList=[CategoryDto(categoryId=29, categoryName=麻醉疼痛科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=25037, guiderKeyword=术前用药, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4667, appHits=43, showAppHits=0, pcHits=302, showPcHits=4624, likes=2, shares=6, comments=2, approvalStatus=1, publishedTime=Tue Nov 16 23:57:01 CST 2021, publishedTimeString=2021-11-01, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Mon Nov 08 21:46:53 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Fri Jan 05 18:20:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 SPAQI共识声明：胃肠道和肺部用药的术前处理.pdf)])
2021 SPAQI共识声明：胃肠道和肺部用药的术前处理.pdf
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1085488, encodeId=1c6d108548805, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2cd5399260, createdName=ms3000000121177566, createdTime=Wed Dec 29 16:15:36 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068352, encodeId=a1a4106835278, content=学习了谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM66WRRAmeqIVSnDN88DpaJfEWzRZxg4yBbiaBmMRwcvViaA2C0sE0Ts3Lic24JSSI4YffujDtpnm0GTHpuiao9TytmNArrcYESnSXY/0, createdBy=7938104912, createdName=jacob9231, createdTime=Tue Nov 09 02:22:28 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-12-29 ms3000000121177566

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1085488, encodeId=1c6d108548805, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2cd5399260, createdName=ms3000000121177566, createdTime=Wed Dec 29 16:15:36 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068352, encodeId=a1a4106835278, content=学习了谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM66WRRAmeqIVSnDN88DpaJfEWzRZxg4yBbiaBmMRwcvViaA2C0sE0Ts3Lic24JSSI4YffujDtpnm0GTHpuiao9TytmNArrcYESnSXY/0, createdBy=7938104912, createdName=jacob9231, createdTime=Tue Nov 09 02:22:28 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-09 jacob9231

    学习了谢谢

    0